IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11998689 B1

PDFFull Text
Date of Patent:
Jun. 04, 2024

Filed:

Nov. 12, 2021

Enhanced performance verification port for therapeutic gas delivery

Applicant:

Mallinckrodt Pharmaceuticals Ireland Limited, Dublin, IE;

Inventors:

Jaron M. Acker, Madison, WI (US);

John C. Falligant, Edgerton, WI (US);

Jeff Milsap, Cambridge, WI (US);

Robin Roehl, Janesville, WI (US);

Jeffrey Schmidt, Fitchburg, WI (US);

Craig R. Tolmie, Stoughton, WI (US);

Assignee:

Mallinckrodt Pharmaceuticals Ireland Limited, Dublin, IE;

Attorney:
Primary Examiner:

Steven O Douglas

Int. Cl.
CPC ...
A61M 16/00 (2006.01); A61M 16/10 (2006.01); A61M 16/12 (2006.01); A61M 16/20 (2006.01); B63C 11/02 (2006.01); G01F 22/02 (2006.01); A61M 16/08 (2006.01);
U.S. Cl.
CPC ...
A61M 16/0051 (2013.01); A61M 16/024 (2017.08); A61M 16/1005 (2014.02); A61M 16/12 (2013.01); A61M 16/122 (2014.02); A61M 16/125 (2014.02); A61M 16/201 (2014.02); A61M 16/202 (2014.02); A61M 16/204 (2014.02); B63C 11/02 (2013.01); G01F 22/02 (2013.01); A61M 2016/0027 (2013.01); A61M 2016/0039 (2013.01); A61M 16/085 (2014.02); A61M 2016/102 (2013.01); A61M 16/208 (2013.01); A61M 2202/0275 (2013.01); A61M 2205/14 (2013.01); A61M 2205/16 (2013.01); A61M 2205/17 (2013.01); A61M 2205/3331 (2013.01); A61M 2205/3334 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/3379 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2205/60 (2013.01); A61M 2205/6018 (2013.01); A61M 2205/6072 (2013.01); A61M 2205/8206 (2013.01); F17C 2250/00 (2013.01);
Abstract

Therapy gas delivery systems that provide run-time-to-empty information to a user of the system and methods for administering therapeutic gas to a patient. The therapeutic gas delivery system may include a gas pressure sensor attachable to a therapeutic gas source that communicates therapeutic gas pressure data to a therapeutic gas delivery system controller, a gas temperature sensor positioned to measure gas temperature in the therapeutic gas source that communicates therapeutic gas temperature data to the therapeutic gas delivery system controller, at least one flow controller that communicates therapeutic gas flow rate data to the therapeutic gas delivery system controller, at least one flow sensor that communicates flow rate data to the therapeutic gas delivery system controller, and at least one display that communicates run-time-to-empty to a user of the therapeutic gas delivery system. The therapeutic gas delivery system controller of the system includes a processor that executes an algorithm to calculate the run-time-to-empty from the data received from the gas pressure sensor, temperature sensor, flow controller and flow sensor, and directs the result to the display.

Find Patent Forward Citations

Loading…